載入...
The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II
Dovitinib (TKI258/CHIR258) is a multi-kinase inhibitor in phase III development for the treatment of several cancers. Dovitinib is a benzimidazole-quinolinone compound that structurally resembles the bisbenzimidazole minor groove binding dye Hoechst 33258. Dovitinib bound to DNA as shown by its abil...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3501595/ https://ncbi.nlm.nih.gov/pubmed/23041231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2012.09.023 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|